Literature DB >> 33565223

The healing effects of facial BOTOX injection on symptoms of depression alongside its effects on beauty preservation.

Mohammad Khademi1, Masoumeh Roohaninasab2, Azadeh Goodarzi2, Farnoosh Seirafianpour3, Milad Dodangeh3, Arash Khademi4.   

Abstract

BACKGROUND: Beauty is closely associated with a sense of calm, confidence, and hope for a better life. Therefore, it is expected that improving the appearance or even correcting one's view of appearance can prevent depression and even improve different degrees of depression in individuals. AIMS: Investigation of whether using botulinum injections (a common method of improving facial esthetics) can improve the degree of depression in clients.
METHODS: This prospective interventional before-after study was conducted on 121 consecutive individuals referred for beautifying the face. Before performing the interventional procedure by facial botulinum injection as well as one month later, the depression status was examined by the Beck Depression Inventory II (BDI) questionnaire.
RESULTS: The mean baseline depression score dropped from 18.9 ± 4.8 to 10.6 ± 2.9 during the follow-up time (P < .001). Using the multivariable linear regression modeling and with the presence of baseline parameters, the main determinants of improving depression score included young ages (beta = -0.541, P = .001), higher educational level (beta = 0.595, P = .015), and previous experiences of botulinum toxin use (beta = 1.072, P = .036).
CONCLUSION: The improvement in people's moods along with correction of their facial defects following botulinum toxin injections would be expected.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  BOTOX; Beauty; Botulinum toxin; Mood

Year:  2021        PMID: 33565223     DOI: 10.1111/jocd.13990

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  5 in total

Review 1.  Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia.

Authors:  Parya Amini; Mehran Amrovani; Zohre Saleh Nassaj; Parisa Ajorlou; Aiyoub Pezeshgi; Bahareh Ghahrodizadehabyaneh
Journal:  Cardiovasc Toxicol       Date:  2022-03-28       Impact factor: 3.231

Review 2.  Treatment of Depression with Botulinum Toxin.

Authors:  Marc Axel Wollmer; Michelle Magid; Tillmann H C Kruger; Eric Finzi
Journal:  Toxins (Basel)       Date:  2022-05-31       Impact factor: 5.075

Review 3.  Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease.

Authors:  Farahnaz Nikdoust; Mahboubeh Pazoki; Mohammadjavad Mohammadtaghizadeh; Mahsa Karimzadeh Aghaali; Mehran Amrovani
Journal:  Cardiovasc Toxicol       Date:  2021-10-20       Impact factor: 2.755

Review 4.  The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword.

Authors:  Mohammad Heydarian; Mohammadjavad Mohammadtaghizadeh; Mahboobeh Shojaei; Marziyeh Babazadeh; Sadegh Abbasian; Mehran Amrovani
Journal:  Mol Biol Rep       Date:  2021-10-16       Impact factor: 2.742

5.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.